Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea
· Delayed Price · Currency is KRW 9,320.00
-200.00 (-2.10%)
May 14, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 221.41 billion as of May 13, 2025. Its market cap has decreased by -45.81% in one year.
Market Cap
221.41B
Enterprise Value
183.37B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,320.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 221.41B, an increase of 38.17%. That is a compound annual growth rate of 7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 221.41B | -7.68% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 375.18T |
| SK hynix | 136.77T |
| LG Energy Solution | 73.01T |
| Samsung Biologics | 70.53T |
| Hyundai Motor Company | 42.87T |
| Hanwha Aerospace | 36.56T |
| Kia Corporation | 36.38T |
| HD Hyundai Heavy Industries | 35.91T |